Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Disease-modifying drugs for multiple sclerosis must be globally available according to therapeutic guidelines suitable to different regions of the world.
Quantitative evaluation of CXCL8 and its receptors (CXCR1 and CXCR2) gene expression in Iranian patients with multiple sclerosis.
Blood Plasma Levels of Microelements in Patients with History of Optic Neuritis.
[Clinical epidemiology of multiple sclerosis in Moscow. Discriptive epidemiology in population of one region of Moscow.]
Treatment of Neuromyelitis Optica Spectrum Disorder: Acute, Preventive, and Symptomatic.
Science to practice: myeloperoxidase immunoradiology improves detection of acute and chronic experimental multiple sclerosis.
Core muscle characteristics during walking of patients with multiple sclerosis.
The relationship between regional microstructural abnormalities of the corpus callosum and physical and cognitive disability in relapsing-remitting multiple sclerosis.
Comparison between balanced steady-state free precession and standard spoiled gradient echo magnetization transfer ratio imaging in multiple sclerosis: methodical and clinical considerations.
Promoting return of function in multiple sclerosis: An integrated approach.
Increased S-nitrosothiols are associated with spinal cord injury in multiple sclerosis.
JC Virus Replication at the First Symptoms of Multiple Sclerosis: A Case Report.
Assessing the Correlation between Grey and White Matter Damage with Motor and Cognitive Impairment in Multiple Sclerosis Patients.
Pro-Inflammatory Cytokines Reduce the Proliferation of NG2 Cells and Increase Shedding of NG2 In Vivo and In Vitro.
The Encephalitogenic, Human Myelin Oligodendrocyte Glycoprotein-Induced Antibody Repertoire Is Directed towards Multiple Epitopes in C57BL/6-Immunized Mice.
The innate immune system in demyelinating disease.
Rituximab treatment did not aggravate ongoing progressive multifocal leukoencephalopathy in a patient with multiple sclerosis.
Reduced expression of membrane-bound (m)RAGE is a biomarker of multiple sclerosis disease progression.
Disconnection of the hippocampus and amygdala associated with lesion load in relapsing-remitting multiple sclerosis: a structural and functional connectivity study.
Modeling disease severity in multiple sclerosis using electronic health records.
Pathologic laughing as a presenting feature in a patient with neuromyelitis optica.
The Olig family affects central nervous system development and disease.
Regulatory B cells, helminths, and multiple sclerosis.
Item response theory-based measure of global disability in multiple sclerosis derived from the Performance Scales and related items.
The impact of persistence with therapy on inpatient admissions and emergency room visits in the US among patients with multiple sclerosis.
Pages
« first
‹ previous
…
396
397
398
399
400
401
402
403
404
…
next ›
last »